N/A
Completed N=56
Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate
Covid19 · Vaccine Refusal
Source: ClinicalTrials.gov NCT04930965 ↗
Enrolled (actual)
56
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcomePrimary: Difference in Proportion of Participants "Likely to Vaccinate" Between Study Arms at Month 1 — 1; 3 Participants
Summary
The purpose of the study is to assess the effectiveness of the HALT COVID Ambassador educational outreach program on increasing likelihood to vaccinate against COVID-19
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Difference in Proportion of Participants "Likely to Vaccinate" Between Study Arms at Month 1 |
1; 3 | — |
| SECONDARY Difference in Proportion of Participants "Likely to Vaccinate" Between Study Arms at Month 2 |
4; 4 | — |
| SECONDARY Difference in Proportion of Participants Who Have Received >=1 Dose of Vaccine Between Study Arms at Month 1 |
1; 2 | — |
| SECONDARY Difference in Proportion of Participants Who Have Received >=1 Dose of Vaccine Between Study Arms at Month 2 |
1; 2 | — |
Eligibility Criteria
Inclusion Criteria
- Unlikely to vaccinate in next month
- Age >=18 years
- Self-identification as Black or African American
- Ability to understand and speak English
- Willingness to engage with HALT COVID Ambassador via in-person or virtual sessions exploring questions and concerns about vaccines
Exclusion Criteria
- Unable or unwilling to give informed consent
Data sourced from ClinicalTrials.gov (NCT04930965). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.